Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05HHG
|
|||
| Drug Name |
PMID27977313-Compound-32
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H9Cl2NO3
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)NC(=O)C(=C(C(=O)O)Cl)Cl
|
|||
| InChI |
1S/C11H9Cl2NO3/c1-6-2-4-7(5-3-6)14-10(15)8(12)9(13)11(16)17/h2-5H,1H3,(H,14,15)(H,16,17)/b9-8+
|
|||
| InChIKey |
LYXYEAXSHFSVNI-CMDGGOBGSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytoplasmic thioredoxin reductase (TXNRD1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cytoplasmic thioredoxin reductase (TXNRD1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.